Trade Clearside Biomedical, Inc. - CLSD CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0256 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024318% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.002096% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.0672 |
| Open | 1.0572 |
| 1-Year Change | 4.95% |
| Day's Range | 1.0172 - 1.0872 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 4, 2024 | 1.0172 | -0.0400 | -3.78% | 1.0572 | 1.0872 | 1.0072 |
| Dec 3, 2024 | 1.0672 | 0.0000 | 0.00% | 1.0672 | 1.0772 | 1.0472 |
| Dec 2, 2024 | 1.0772 | 0.0300 | 2.86% | 1.0472 | 1.0972 | 1.0472 |
| Nov 29, 2024 | 1.0572 | 0.0000 | 0.00% | 1.0572 | 1.0572 | 1.0372 |
| Nov 27, 2024 | 1.0672 | -0.0100 | -0.93% | 1.0772 | 1.0872 | 1.0472 |
| Nov 26, 2024 | 1.0772 | -0.0100 | -0.92% | 1.0872 | 1.0972 | 1.0572 |
| Nov 25, 2024 | 1.0972 | 0.0200 | 1.86% | 1.0772 | 1.1072 | 1.0572 |
| Nov 22, 2024 | 1.0672 | 0.0500 | 4.92% | 1.0172 | 1.0672 | 1.0172 |
| Nov 21, 2024 | 1.0172 | -0.0300 | -2.86% | 1.0472 | 1.0672 | 1.0072 |
| Nov 20, 2024 | 1.0472 | 0.0200 | 1.95% | 1.0272 | 1.0572 | 1.0172 |
| Nov 19, 2024 | 1.0272 | 0.0000 | 0.00% | 1.0272 | 1.0472 | 0.9972 |
| Nov 18, 2024 | 1.0172 | 0.0300 | 3.04% | 0.9872 | 1.0272 | 0.9851 |
| Nov 15, 2024 | 0.9872 | -0.0600 | -5.73% | 1.0472 | 1.0472 | 0.9674 |
| Nov 14, 2024 | 1.0472 | -0.0100 | -0.95% | 1.0572 | 1.0672 | 1.0372 |
| Nov 13, 2024 | 1.0672 | -0.0200 | -1.84% | 1.0872 | 1.0972 | 1.0472 |
| Nov 12, 2024 | 1.0972 | 0.0200 | 1.86% | 1.0772 | 1.1472 | 1.0772 |
| Nov 11, 2024 | 1.0872 | -0.0400 | -3.55% | 1.1272 | 1.1372 | 1.0572 |
| Nov 8, 2024 | 1.1372 | 0.0400 | 3.65% | 1.0972 | 1.1472 | 1.0872 |
| Nov 7, 2024 | 1.1072 | 0.0100 | 0.91% | 1.0972 | 1.1172 | 1.0572 |
| Nov 6, 2024 | 1.0772 | 0.0100 | 0.94% | 1.0672 | 1.0972 | 1.0472 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Clearside Biomedical, Inc. Company profile
About Clearside Biomedical Inc
Clearside Biomedical, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases. Its proprietary suprachoroidal space (SCS) microinjector targeting SCS offers access to the macula, retina and choroid where sight-threatening disease often occurs. The SCS injection platform is an inherently flexible, in-office, non-surgical procedure intended to provide targeted delivery to the site of disease and to work with both established and new formulations of medications, as well as future therapeutic innovations. The Company’s suprachoroidal injection platform is a patented approach for delivering pharmacotherapy to the back of the eye through SCS. The Company’s lead product candidate, XIPERE, is a preservative-free suspension of the corticosteroid triamcinolone acetonide (TA), formulated for administration through suprachoroidal injection.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Clearside Biomedical Inc revenues increased from $7.9M to $29.6M. Net income totaled $376K vs. loss of $18.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Other expense decrease from $275K (expense) to $0K. Basic Earnings per Share excluding Extraordinary Items increased from -$0.39 to $0.01.
| Industry: | Bio Therapeutic Drugs |
900 North Point Parkway
Suite 200
ALPHARETTA
GEORGIA 30005
US
News
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
09:32, 4 December 2024
Silver price forecast 2025 and beyond: Third party price target
Rising interest rates and a strong dollar pushed silver to a two-year last September, but what lies ahead?
16:00, 3 December 2024
Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
16:41, 28 November 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
15:17, 18 November 2024
Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024
Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com